Sharing Trial Data

It is time that drug companies get with the program and accept that sharing of clinical trials data is a good thing, and should be more widely adopted, at the very least because it could engender more trust between pharmaceutical companies and patients, Nature writes in an editorial.

The comments were published on the heels of a new UK government report which said that drug makers have been routinely hiding clinical trial information from researchers and doctors.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.